Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramDirector, CEOCIK 0001871714
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 42 | Giordano Christopher ThomasDirector, CEO |  TENXTENAX THERAPEUTICS, INC.Open-market purchase | BUY | $11K 6,000 sh | Sep 15, 2026 traded Sep 11, 2026 | |
Giordano Christopher ThomasDirector, CEO |
| TENXTENAX THERAPEUTICS, INC. Open-market purchase |
| BUY |
| $8,837 4,850 sh |
| Sep 15, 2026 traded Sep 15, 2026 |
| 5 | Giordano Christopher ThomasDirector, CEO | TENXTENAX THERAPEUTICS, INC. Grant or award | A | — 450.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 38 | Giordano Christopher ThomasDirector, CEO | TENXTENAX THERAPEUTICS, INC. Open-market purchase | BUY | $3,417 455 sh | Nov 20, 2025 traded Nov 19, 2025 |
| 38 | Giordano Christopher ThomasDirector, CEO | TENXTENAX THERAPEUTICS, INC. Open-market purchase | BUY | $4,083 538 sh | Nov 20, 2025 traded Nov 20, 2025 |
| 46 | Giordano Christopher ThomasDirector, CEO | TENXTENAX THERAPEUTICS, INC. Open-market purchase | BUY | $13K 1,612 sh | Nov 20, 2025 traded Nov 18, 2025 |